Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (311-320 of 406) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Journal for Immunotherapy of Cancer|December 23, 2022
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI studyBrendan D Curti, Jon Richards, John R Hyngstrom, et al.
Stomatologiia|November 1, 1990
[The use of discriminant analysis for the differential diagnosis of periodontal diseases]A A Prokhonchukov, N E Aĭnbinder, S V Ul'ianov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumorsRobert J Motzer, Craig J Nichols, Kim A Margolin, et al.
Cancer|January 28, 2012
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancerPhuong Khanh Morrow, Rashmi K Murthy, Joe D Ensor, et al.
Nature Biotechnology|September 11, 2009
Genome-wide identification of post-translational modulators of transcription factor activity in human B cellsKai Wang, Masumichi Saito, Brygida C Bisikirska, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 13, 2015
The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse modelDavid A Margolin, Tamara Myers, Xin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
BMC Bioinformatics|February 2, 2018
Germline contamination and leakage in whole genome somatic single nucleotide variant detectionDorota H Sendorek, Cristian Caloian, Kyle Ellrott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)David H Lawson, Sandra Lee, Fengmin Zhao, et al.
Pageof 41

Showing results (311-320 of 406) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Journal for Immunotherapy of Cancer|December 23, 2022
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI studyBrendan D Curti, Jon Richards, John R Hyngstrom, et al.
Stomatologiia|November 1, 1990
[The use of discriminant analysis for the differential diagnosis of periodontal diseases]A A Prokhonchukov, N E Aĭnbinder, S V Ul'ianov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumorsRobert J Motzer, Craig J Nichols, Kim A Margolin, et al.
Cancer|January 28, 2012
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancerPhuong Khanh Morrow, Rashmi K Murthy, Joe D Ensor, et al.
Nature Biotechnology|September 11, 2009
Genome-wide identification of post-translational modulators of transcription factor activity in human B cellsKai Wang, Masumichi Saito, Brygida C Bisikirska, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 13, 2015
The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse modelDavid A Margolin, Tamara Myers, Xin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
BMC Bioinformatics|February 2, 2018
Germline contamination and leakage in whole genome somatic single nucleotide variant detectionDorota H Sendorek, Cristian Caloian, Kyle Ellrott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)David H Lawson, Sandra Lee, Fengmin Zhao, et al.
Pageof 41